Amarin Corp Plc (AMRN)

[Retired2019]

Email sent to Amarin IR (Lisa) this morning:

When you have time, could you provide commentary regarding options and timeframes to grow the U.S. market vs. Amarin losing 30% of the U.S. market over the last 18 months?

Amarin's share price is grossly undervalued and has been for the past 1-2 years. Amarin Leadership and the BOD have been unable to gain traction in the U.S. and EU. Losing market share to generics in the U.S. and GIA slow walk, paper pushing strategy in the EU is resulting in the share price being range bound between $3 - $3.50. You're running out of time.

This is unacceptable to shareholders.

I am requesting Amarin authorize a review of strategic alternatives to maximize shareholder value. As part of this process, evaluate partnerships in the U.S. and EU geos, a sale of the company, as well as a range of alternatives, including separate sales of business units; U.S, EU, ROW. I would like to see Alex Denner included in this process.

Please let me know leadership's comments regarding my request to maximize shareholder value.